Swiss-based Comphya raises €8M to restore erectile function in patients non-responsive to oral drugs
Lausanne, Switzerland-based Comphya, a clinical-stage medtech company, has closed an oversubscribed Series A funding round at CHF 7.5M (approximately €8.07M).